Orchid Pharma Ltd (ORCHIDPHAR):企業の財務・戦略的SWOT分析

◆英語タイトル:Orchid Pharma Ltd (ORCHIDPHAR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH63309FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Orchid Pharma Ltd (Orchid), formerly Orchid Chemicals & Pharmaceuticals Ltd is a pharmaceutical company that develops and manufactures pharmaceutical solutions such as formulations and API products. The company offers formulations such as cardiovascular products, neuropsychiatry products, anti-diabetic products, nutritional supplements and various other products. It provides API such as cephalosporins-orals, cephalosporins-injectibles, veterinary products and non-antibiotics, among others. Orchid offers veterinary products, which include cefalonium, cefquinome sulphate, ceftiofur hydrochloride and ceftiofur sodium, among others. The company provides services such as process and pharma research, new drug discovery, pre-clinical research, biotech research, intellectual property management and contract research, among others. It has presence in the UK, South Africa, India, the US and Ukraine, among others. Orchid is headquartered in Chennai, Tamil Nadu, India.

This comprehensive SWOT profile of Orchid Pharma Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Orchid Pharma Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Orchid Pharma Ltd – Key Information
Orchid Pharma Ltd – Overview
Orchid Pharma Ltd – Key Employees
Orchid Pharma Ltd – Key Employee Biographies
Orchid Pharma Ltd – Key Operational Heads
Orchid Pharma Ltd – Major Products and Services
Orchid Pharma Ltd – History
Orchid Pharma Ltd – Company Statement
Orchid Pharma Ltd – Locations And Subsidiaries
Orchid Pharma Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Orchid Pharma Ltd – Business Description
Orchid Pharma Ltd – Corporate Strategy
Orchid Pharma Ltd – SWOT Analysis
SWOT Analysis – Overview
Orchid Pharma Ltd – Strengths
Orchid Pharma Ltd – Weaknesses
Orchid Pharma Ltd – Opportunities
Orchid Pharma Ltd – Threats
Orchid Pharma Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Orchid Pharma Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Orchid Pharma Ltd, Key Information
Orchid Pharma Ltd, Key Ratios
Orchid Pharma Ltd, Share Data
Orchid Pharma Ltd, Major Products and Services
Orchid Pharma Ltd, History
Orchid Pharma Ltd, Key Employees
Orchid Pharma Ltd, Key Employee Biographies
Orchid Pharma Ltd, Key Operational Heads
Orchid Pharma Ltd, Other Locations
Orchid Pharma Ltd, Subsidiaries
Orchid Pharma Ltd, Key Competitors
Orchid Pharma Ltd, SWOT Analysis
Orchid Pharma Ltd, Ratios based on current share price
Orchid Pharma Ltd, Annual Ratios
Orchid Pharma Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Orchid Pharma Ltd (ORCHIDPHAR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • International Isotopes Inc (INIS)-医療機器分野:企業M&A・提携分析
    Summary International Isotopes Inc (INIS) is a provider of medical teletherapy products. The company offers radioisotope products for cancer therapy, nuclear medicine and industrial processes. It offers cobalt and radiochemical products and nuclear medicine calibration standards. INIS's cobalt and r …
  • Surgical Specialties Corp:企業の戦略・SWOT・財務分析
    Surgical Specialties Corp - Strategy, SWOT and Corporate Finance Report Summary Surgical Specialties Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Trinity Biotech Plc (TRIB):医療機器:M&Aディール及び事業提携情報
    Summary Trinity Biotech Plc (Trinity Biotech) is a medical equipment company which develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company’s product portfolio encompasses diagnostic tests and instruments that are used to dete …
  • Apollo Education Group, Inc.:企業の戦略・SWOT・財務情報
    Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Hill-Rom Holdings, Inc.:戦略・SWOT・企業財務分析
    Hill-Rom Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hill-Rom Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Colfax Corp (CFX):石油・ガス:M&Aディール及び事業提携情報
    Summary Colfax Corp (Colfax) is a manufacturing and engineering company. The company supplies a wide range of products, including heavy-duty centrifugal and axial fans, gas compressors, rotary heat exchangers, and centrifugal and positive displacement pumps; and consumable products and equipment for …
  • China Medical System Holdings Ltd (867):製薬・医療:M&Aディール及び事業提携情報
    Summary China Medical System Holdings Ltd (CMS) is a pharmaceutical service provider that markets, promotes, and sells prescription drugs to all therapeutic departments in hospitals. The company offers products such as deanxit, ursofalk, augentropfen stulln mono eye-drops, exacin, xinhuosu, salofalk …
  • Ternium SA:戦略・SWOT・企業財務分析
    Ternium SA - Strategy, SWOT and Corporate Finance Report Summary Ternium SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Grupo Juste SAQF-製薬・医療分野:企業M&A・提携分析
    Summary Grupo Juste SAQF (Juste) discovers, develops and distributes pharmaceutical products and active pharmaceutical ingredients (APIs). It develops and manufactures oral and injectable radiological contrast media; antidepressants, oral contraceptives, prebiotic formulations for the prevention of …
  • Phagelux Inc-製薬・医療分野:企業M&A・提携分析
    Summary Phagelux Inc (Phagelux) is an anti-infectives company that provides antibacterial products and solutions. The company uses phage lysis enzymes and biological agents for the treatment of antibiotic resistant bacteria and related diseases in human beings and crops. Its product portfolio includ …
  • DFDS AS (DFDS):企業の財務・戦略的SWOT分析
    DFDS AS (DFDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • RHI AG:戦略・SWOT・企業財務分析
    RHI AG - Strategy, SWOT and Corporate Finance Report Summary RHI AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • NOW Inc (DNOW):企業の財務・戦略的SWOT分析
    NOW Inc (DNOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Ausenco Ltd:企業の戦略・SWOT・財務情報
    Ausenco Ltd - Strategy, SWOT and Corporate Finance Report Summary Ausenco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Promedior Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Promedior Inc (Promedior) is a clinical-stage biotechnology company that develops medicines for the treatment of fibrotic disorders. The company’s pipeline products include PRM-151 and PRM-167. PRM-151 is used in the treatment of rare systemic fibrotic diseases such as myelofibrosis and idio …
  • Bioxyne Ltd (BXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioxyne Ltd (Bioxyne), is a biotechnology company that develops, manufactures, markets and commercializes healthcare products in the areas of immune health and immunotherapeutics. It manufactures consumer food supplements such as, ProTract and Progastrim, which are based on a proprietary pro …
  • Tohoku Electric Power Co Inc (9506):企業の財務・戦略的SWOT分析
    Tohoku Electric Power Co Inc (9506) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • United Therapeutics Corp (UTHR):企業の製品パイプライン分析
    Summary United Therapeutics Corp (United Therapeutics) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The company's products consist of prostacyclin analogues includin …
  • Sri Ayudhya Capital Public Company Limited:企業の戦略・SWOT・財務分析
    Sri Ayudhya Capital Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sri Ayudhya Capital Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Oxford BioMedica Plc (OXB):製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford BioMedica plc (Oxford Biomedica) is a gene and cell therapy company that focuses on developing novel treatments for serious diseases. The company along with its subsidiaries has developed LentiVector, a sector leading lentiviral vector delivery platform. It has also built a platform o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆